Nova Eye Medical Limited

EYE.ASX

Health Care

Medical devices manufacturer.

Market Data

Price

$0.110

+0.0%

Market Cap

$31.3M

P/E Ratio

-100000.0x

EPS

$-0.026

Div. Yield

0.00%

52-Week Change

-0.3%

Recent Announcements

26 Feb 2026 Supplementary Neutral

Investor Presentation Half Year Results

Nova Eye Medical Limited (ASX: EYE) released its investor presentation for the half-year ended 31 December 2025, reporting record revenue of A$16.7 million (up 31% on prior comparable period) with continued strong USA sales growth at 40% CAGR over six consecutive halves, positive EBITDA achieved in December 2025, and improved underlying cash flow from operations.

Get real-time alerts for EYE

Receive AI-powered earnings summaries and instant notifications when Nova Eye Medical Limited releases results.